NICE Price: Zytiga On Track In England After Discount
This article was originally published in The Pink Sheet Daily
Executive Summary
Janssen’s decision to offer the NHS a discount for its oral prostate cancer treatment Zytiga appears to have paid off, giving the drug a boost and head start over potential rivals in the EU.